文章核心观点 - ICU Medical在2026年9月止季度实现营收5.5622亿美元，同比增长4.3%，超出Zacks共识预期的5.5315亿美元，意外惊喜为+0.55% [1] - 同季度每股收益为2.44美元，相比去年同期的2.03美元有所提升，超出共识预期的2.14美元，EPS意外惊喜达+14.02% [1] - 投资者除关注营收和盈利的同比变化及与华尔街预期的比较外，部分关键指标能更好揭示公司底层经营表现，将这些指标与去年同期及分析师预期对比有助于更准确预测股价表现 [2] - ICU Medical股价过去一个月回报率为+10.6%，而Zacks标普500综合指数同期变化为-0.4% [3] 分项业务营收表现 - 输液系统业务营收为1.925亿美元，高于两位分析师平均预期的1.8397亿美元 [4] - Vital Care业务营收为6950万美元，低于两位分析师平均预期的7709万美元 [4] - 耗材业务营收为2.984亿美元，高于两位分析师平均预期的2.962亿美元 [4]

ICU Medical (NasdaqGS:ICUI) Q3 2026 Earnings call November 05, 2026 04:30 PM ET Company Participants Deirdre Thomson - SVP of Investor Relations Vivek Jain - CEO and Chairman Brian Bonnell - CFO Conference Call Participants Jayson Bedford - Analyst Larry Solow - Analyst None - Analyst Brett Fishbin - Analyst Mike Matson - Analyst Sam Eiber - Analyst Operator Good afternoon, everyone, and welcome to today's ICU Medical Inc Third Quarter 2026 Earnings Conference Call. All participants will be in listen-only m ...

ICU Medical (NasdaqGS:ICUI) Q3 2026 Earnings call November 05, 2026 04:30 PM ET Speaker0Good afternoon, everyone, and welcome to today's ICU Medical Inc. third quarter 2026 earnings conference call. All participants will be in listen-only mode. After today's presentation, there will be an opportunity to ask questions. To ask a question at that time, please press star one. Also, please note that today's event is being recorded. I'd now like to turn the conference over to Deirdre Thomson, ICR Senior Vice Pres ...

SAN CLEMENTE, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended September 30, 2026. Third Quarter 2026 Results Third quarter 2026 GAAP revenue was $560.4 million, as compared to $537.0 million in the same period in the prior year. GAAP gross profit for the third quarter of 2026 was $234.8 million, as compared to $200.9 million in the same ...